Advanced Therapies Congress & Expo 2020 – “ImmunoTox: Genetic Manipulation of Solid Tumors to Activate the Natural Gamma Delta (γδ) T Cell Response”

Advanced Therapies Congress & Expo 2020 - ImmunoTox: Genetic Manipulation of Solid Tumors to Activate the Natural Gamma Delta (γδ) T Cell Response

Subscribe to our YouTube Channel By: Former Chief Science Officer C. David Pauza, Ph.D., American Gene Technologies Description: On September 2, 2020, at the Advanced Therapies Congress & Expo 2020 Conference, Former Chief Science Officer Dr. C. David Pauza Presented “ImmunoTox: Genetic Manipulation of Solid Tumors to Activate the Natural Gamma Delta (γδ) T Cell…

Read More

Advanced Therapies Congress & Expo 2020 – “At the Intersection of Genetic Medicine and Immunotherapy: Clinical Experience with a Cell and Gene Therapy for HIV Disease”

Advanced Therapies Congress & Expo 2020 - At the Intersection of Genetic Medicine and Immunotherapy: Clinical Experience with a Cell and Gene Therapy for HIV Disease

Subscribe to our YouTube Channel By: Former Chief Science Officer C. David Pauza, Ph.D., American Gene Technologies At the Advanced Therapies Congress & Expo 2020 Conference on August 31, 2020, former Chief Science Officer C. David Pauza, Ph.D., of American Gene Technologies Presented “At the Intersection of Genetic Medicine and Immunotherapy: Clinical Experience with a…

Read More

The History of HIV Cure Research: Discovery to Treatment

The History of HIV Cure Research: Discovery to Treatment

Contributing Author: Gina Hagler When reports of a new immune deficiency disease hit the news in the summer and fall of 1981, the cause and method of transmission were unknown. At first, it seemed this new disease only affected gay men and, as a result, what is now known as HIV/AIDS was viewed by many as the…

Read More

Gene Therapy: More than Monogenic Disease

Gene Therapy: More than Monogenic Disease

Contributing Author John Vandermosten, Senior Biotechnology Analyst Gene therapy is a diverse technology that can address a broad variety of diseases, conditions and disorders.  About a year ago, the FDA approved its latest gene therapy product, Zolgensma, for spinal muscular atrophy (SMA), a neuromuscular disorder caused by a mutation in the SMN1 gene.  Gene therapy is…

Read More

Treatment of Rare Diseases: What You Need to Know

Treatment of Rare Diseases: What You Need to Know

Contributing writer: Gina Hagler An emerging drug development model has the potential to reduce the cost of treatments for rare diseases. What is a Rare Disease? The definition of a rare disease varies by country, with the consensus that a rare disease or condition is one that affects far less than 1% of the population.…

Read More

Can HIV Be Cured? These Two HIV+ Clinical Trial Participants Believe It Can

Can HIV Be Cured? These Two HIV+ Clinical Trial Participants Believe It Can

Subscribe to our YouTube Channel Now on the edge of 2020, we’re closer than ever to finding a legitimate therapy to eradicate HIV. Companies like AGT are doing groundbreaking research and developing innovative ways to combat the virus, but without volunteers to participate in clinical trials, efforts to develop a cure could quickly be slowed.…

Read More

Is HIV Curable?

Is HIV curable?

Is HIV Curable? American Gene Technologies® (AGT™) believes it is. Read why AGT’s Chief Science Officer is committed to discovering a cure for HIV during our lifetime. Written by: Dr. David Pauza Learn More In 1987, Robert Yarchoan and Samuel Broder provided a progress report (New England J. Med 316:557) on the initial efforts to…

Read More

HIV Cure in the News

Second Patient Cured of HIV and The Implications for American Gene Technologies's AGT103-T

Today the world celebrated the second patient cured of HIV. The work of Ravindra Gupta teaches us lessons not only of the potential for an HIV cure in the future, but how that cure may function. While a bone marrow transplant is not a practical way to cure HIV in most patients, the mechanism of…

Read More

Why Invest in an HIV Gene Therapy Cure?

Why Invest in an HIV Gene Therapy Cure

Research and innovation to cure HIV is developing fast. American Gene Technologies® (AGT™)  is emerging as a leader in the field with their first functional cure for HIV, expected to enter clinical trials in 2019. Unlike the current antiretrovirals used in HIV treatment, AGT’s solution is a one-time intervention that eliminates the need for ongoing antiretrovirals,…

Read More

The Next Generation of Gene Therapy Companies

The Next Generation of Gene Therapy Companies

The future of medicine is bright. This year brought several first in class technologies over the finish line. The underpinning of these radical medical developments is the understanding of how human genes can be modified to cure diseases and save lives. The technology which captured the most attention this year is CAR-T therapy. A CAR-T…

Read More